Description
This product utilizes Synthetic CD4+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target EGP2 (clone HEA-1F3). We employs the HBV (p15A-Cy5-LEF/TCF-XbaI) vector components and the SynExpress system of the DNA methylation sites Knock-in/Positive feedback for a robust and sustained response against cancers.
Host
Mouse
Target
EGP2
Clone
HEA-1F3
Species Reactivity
Human
Cell Source
Synthetic CD4+ T cells
Sensor Gene
Cy5
Promoter
p15A
Effector Gene
LEF/TCF
Insertion Sites
XbaI
Gene Modification
Knock-in
Modification Domain
DNA methylation sites
Carrier Type
HBV
Transformation Accuracy
0.97
Cell Culture
Suspension Culture

For Research Use Only | Not For Clinical Use

Online Inquiry
Related Products
Copyright © 2025 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.